Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Mar 2026 and Jun 2026.
- Largest single sale: $5.2M (308,477 shares) of Adaptive Biotechnologies Corp on Nov 21, 2025. Filing
- Last sale before this period: Mar 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Jun 26, 2019 | Jun 30, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 29, 2026, Adaptive Biotechnologies Corp: sold 154,768 shares for $3.3M, under a disclosed plan; 103,295 shares acquired by exercising options. 1 filing: 1
- Jun 26, 2026, Adaptive Biotechnologies Corp: sold 11,034 shares for $232K, under a disclosed plan; 11,034 shares acquired by exercising options. 1 filing: 1
- Mar 11, 2026, Adaptive Biotechnologies Corp: sold 63,103 shares for $831K, to cover taxes. 1 filing: 1
- Mar 4, 2026, Adaptive Biotechnologies Corp: 39,063 shares awarded. 1 filing: 1
- Dec 4, 2025, Adaptive Biotechnologies Corp: sold 12,604 shares for $212K, under a disclosed plan; 12,604 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.